Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system

Journal of Clinical Oncology

Volumn 15, Issue 3, 1997, Pages 1039-1051

  Buzaid, A C ^a   Ross, M I ^a   Balch, C M ^a   Soong, S J ^a   McCarthy, W H ^a   Tinoco, L ^a   Mansfield, P ^a   Lee, J E ^a   Bedikian, A ^a   Eton, O ^a   Plager, C ^a   Papadopoulos, N ^a   Legha, S S ^a   Benjamin, R S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURVIVAL RATE;

EID: 0031043697     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.3.1039     Document Type: Article

References (55)

1. American Joint Committee on Cancer: Manual for Staging of Cancer (ed 4). Philadelphia, PA, Lippincott, 1992, pp 143-148
2. Clark W Jr, From L, Bernardino E, et al: The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29:705-726, 1969
3. Breslow A: Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172:902-908, 1970
4. Vollmer R: Malignant melanoma. A multivariate analysis of prognostic factors. Pathol Annu 24:383-407, 1989
5. Morton D, Davtyan D, Wanek L, et al: Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness. Cancer 71:3737-3743, 1993
6. Büttner P, Garbe C, Bertz J, et al: Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. Cancer 75:2499-2506, 1995
7. Lock-Andersen J, Hou-Jensen K, Hansen J, et al: Observer variation in histological classification of cutaneous malignant melanoma. Scand J Plast Reconstr Surg Hand Surg 29:141-148, 1995
8. Balch C, Murad T, Soong S, et al: A multifactorial analysis of melanoma: Prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg 188:732-742, 1978
9. Balch C: Cutaneous melanoma: Prognosis and treatment results worldwide. Semin Surg Oncol 8:400-414, 1992
10. Coit D, Sauven P, Brennan M: Prognosis of thick cutaneous melanoma of the trunk and extremity. Arch Surg 125:322-326, 1990
11. Crowley N, Seigler H: The role of elective lymph node dissection in the management of patients with thick cutaneous melanoma. Cancer 66:2522-2527, 1990
12. Singletary S, Tucker S, Boddie A: Multivariate analysis of prognostic factors in regional cutaneous metastases of extremity melanoma. Cancer 61:1437-1440, 1988
13. Roses D, Karp N, Oratz R, et al: Survival with regional and distant metastases from cutaneous malignant melanoma. Surg Gynecol Obstet 172:262-268, 1991
14. Sutherland C, Mather F, Krementz E: Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion. Surg Gynecol Obstet 164:111-118, 1987
15. Karakousis C, Temple D, Moore R, et al: Prognostic parameters in recurrent malignant melanoma. Cancer 52:575-579, 1983
16. Häffner A, Garbe C, Burg G, et al: The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients. Br J Cancer 66:856-861, 1992
17. Cascinelli N, Bufalino R, Marolda R, et al: Regional non-nodal metastases of cutaneous melanoma. Eur J Surg Oncol 12:175-180, 1986
18. Creagan E, Dalton R, Ahmann D, et al: Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma. J Clin Oncol 13:2776-2783, 1995
19. Coit D: Prognostic factors in patients with melanoma metastatic to regional nodes. Surg Oncol Clin North Am 1:281-295, 1992
20. Buzaid A, Tinoco L, Jendiroba D, et al: Prognostic value of size of lymph node metastases in patients with cutaneous melanoma. J Clin Oncol 13:2361-2368, 1995
21. Karakousis C, Seddip M, Moore R: Prognostic value of lymph node dissection in malignant melanoma. Arch Surg 115:719-722, 1980
22. Karakousis C, Hena M, Emrich L, et al: Axillary node dissection in malignant melanoma: Results and complications. Surgery 108:10-17, 1990
23. Kirkwood J, Strawderman M, Ernstoff M, et al: Interferon-alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 14:7-17, 1996
24. Cascinelli N, Vaglini M, Nava M, et al: Prognosis of skin melanoma with regional node metastases (stage II). Surg Oncol 25:240-247, 1984
25. Callery C, Cochran A, Roe D, et al: Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. Ann Surg 196:69-75, 1982
26. Morton D, Wanek L, Nizze L, et al: Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Ann Surg 214:491-499, 1991
27. Singletary S, Shallenberger R, Guinee V, et al: Melanoma with metastasis to regional axillary or inguinal lymph nodes: Prognostic factors and results of surgical treatment in 714 patients. South Med J 81:5-9, 1988
28. Cavaliere R, Cavaliere F, Deraco M, et al: Hyperthermic antiblastic perfusion in the treatment of stage IIIA-IIIAB melanoma patients. Comparison of two experiences. Mel Res 4:5-11, 1994
29. Cavaliere R, Mondovi B, Moricca G, et al: Regional perfusion hyperthermia, in Storm F (ed): Hyperthermia in Cancer Therapy. Boston, MA, G Hall, 1983, pp 369-399
30. Bass P, Schrafford Koops H, Haekstra H, et al: Isolated regional perfusion in the treatment of melanoma of the extremities. Reg Cancer Treat 1:33-36, 1988
31. Krementz E: Regional perfusion: Current sophistication, what next? Cancer 37:416-432, 1986
32. Stehlin J, Giovanella G, Gutuerrez R, et al: Fifteen year's experience with hyperthermic perfusion for the treatment of soft tissue sarcoma and malignant melanoma of the extremities. Front Radiat Ther Oncol 18:177-182, 1984
33. León P, Daly J, Synnestvedt M, et al: The prognostic implications of microscopic satellites in patients with clinical stage I melanoma. Arch Surg 126:1461-1468, 1991
34. Day CJ, Harrist T, Gorstein F, et al: Malignant melanoma: Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat. Ann Surg 194:108-112, 1981
35. Harrist T, Rigel D, Day C Jr, et al: "Microscopic satellites" are more highly associated with regional lymph node metastases than with primary melanoma thickness. Cancer 53:2183-2187, 1984
36. Ross M, Balch C: The current management of cutaneous melanoma. Adv Surg 24:139-200, 1991
37. Reintgen D, Vollmer R, Tso C, et al: Prognosis for recurrent stage I malignant melanoma. Arch Surg 122:1338-1342, 1987
38. Urist M, Balch C, Milton G: Surgical management of the primary melanoma, in Balch C, Milton G (eds): Cutaneous Melanoma. Clinical Management and Treatment Results Worldwide. Philadelphia, PA, Lippincott, 1985, pp 71-81
39. Brown C, Zitelli J: The prognosis and treatment of true local cutaneous recurrent malignant melanoma. Dermatol Surg 21:285-290, 1995
40. Ketcham A, Moffat F, Balch C: Classification and staging, in Balch C, Houghton A, Milton G, et al (eds): Cutaneous Melanoma. Philadelphia, PA, Lippincott, 1992, pp 213-220
41. Coit D, Rogatko A, Brennan M: Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis. Ann Surg 214:627-636, 1991
42. Bevilacqua R, Coit D, Rogatka A, et al: Axillary dissection in melanoma: Prognostic variables in node-positive patients. Ann Surg 212:125-131, 1990
43. Karakousis C, Goumas W, Rao U, et al: Axillary node dissection in malignant melanoma. Am J Surg 162:202-207, 1991
44. Drepper H, Bieß B, Hofherr B, et al: The prognosis of patients with stage III melanoma. Cancer 71:1239-1246, 1993
45. Balch C, Soong S-J, Shaw H, et al: An analysis of prognostic factors in 8500 patients with cutaneous melanoma, in Balch C, Houghton A, Milton G, et al (eds): Cutaneous Melanoma (ed 2). Philadelphia, PA, Lippincott, 1992, pp 165-187
46. Cohen M, Ketcham A, Felix E, et al: Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg 186:635-642, 1977
47. Day CJ, Sober A, Lew R, et al: Malignant melanoma patients with positive nodes and relatively good prognoses: Microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes. Cancer 47:955-962, 1981
48. Balch C, Soong S-J, Murad T, et al: A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg 193:377-388, 1981
49. Roses D, Provet J, Harris M, et al: Prognosis of patients with pathologic stage II cutaneous malignant melanoma. Ann Surg 201:103-107, 1985
50. Koh H, Sober A, Day CJ, et al: Prognosis of clinical stage I melanoma patients with positive elective regional node dissection. J Clin Oncol 4:1238-1244, 1986
51. Kissin M, Simpson D, Easton D, et al: Prognostic factors related to survival and groin recurrence following therapeutic lymph node dissection for lower limb malignant melanoma. Br J Surg 74:1023-1026, 1987
52. Slingluff CJ, Vollmer R, Seigler H: Stage II malignant melanoma: Presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients. J Surg Oncol 39:139-147, 1988
53. Calabro A, Singletary S, Balch C: Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg 124:1051-1055, 1989
54. Singletary S, Shallenberger R, Guinee V: Surgical management of groin nodal metastases from primary melanoma of the lower extremity. Surg Gynecol Obstet 174:195-200, 1992
55. Cascinelli N, Bufalino R, Morabito A, et al: Results of adjuvant interferon study in WHO melanoma programme. Lancet 343:913-914, 1994